Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study

相似書籍

• Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study
  由: Yamanaka, Hisashi, et al.
  出版: (2016)
• Extended‐Release Once‐Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate‐Release Tofacitinib and Impact of Food
  由: Lamba, Manisha, et al.
  出版: (2016)
• Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study
  由: Tanaka, Yoshiya, et al.
  出版: (2015)
• Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy
  由: Winthrop, Kevin L., et al.
  出版: (2017)
• Phase 1 Dose‐Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers
  由: Miyoshi, So, et al.
  出版: (2019)